Second Front Systems Announces 10 Customers Prepared to Deploy on AWS European Sovereign Cloud via Game Warden ® Platform
3.12.2025 15:30:00 EET | Business Wire | Press release
Second Front Systems (2F), a Technology Partner in the Amazon Web Services (AWS) Partner Network (APN) and Global Security and Compliance Acceleration (GSCA) Program, today announced that ten of its existing customers have prepared for deployment onto AWS European Sovereign Cloud (ESC) via its 2F Game Warden® platform. This builds on Second Front's September announcement that 2F Game Warden will serve as an on-ramp to ESC.
Independent software vendors (ISVs) seeking to support European organizations face complex regulatory requirements, including Germany's C5, and the EU's Digital Operational Resilience Act (DORA) and NIS2 Directive. By leveraging 2F Game Warden, ISVs can inherit a number of controls and expedite compliance with security frameworks. This collaboration unlocks a pre-validated solution for ISVs to meet these stringent compliance requirements while maintaining data residency within EU borders.
“Everything we do at Second Front is about helping our customers meet their end users where they need them, as efficiently and securely as possible,” said Mamie Cruse, Chief Mission Officer at Second Front. “It’s so exciting to see our customers lean into ESC and set the stage to reap the benefits of expanding into the European market.”
To accelerate compliance with the strict requirements of the European Sovereign Cloud, Second Front partners with SecureIT as an ongoing compliance advisor to our ISV customers. SecureIT is a leading provider of cybersecurity and compliance advisory services and solutions to cloud service providers, large enterprises and organizations serving the global public sector.
“Second Front’s customer base encompasses exactly the type of solutions European buyers are wanting to adopt,” said David Trout, President and CEO of SecureIT. “We’re excited to partner with Second Front and their customers to help streamline their availability to the European market.”
The following Second Front customers are early adopters and ready to deploy to ESC once available in 2026:
Accrete, Inc. is a dual-use AI company providing specialized, high-performance Expert AI Agents to government and commercial customers. Built on Accrete’s Knowledge Engine platform, these analytical Expert AI Agents encode institutional knowledge, judgment, and expertise to perform complex analytical work and deliver decision superiority.
Avathon delivers industrial autonomy powered by AI and knowledge graphs, enabling organizations to connect data, decisions, and execution across operations. Its Autonomy Platform brings decision intelligence and execution to the world’s most critical industries, empowering safer, more resilient, and more efficient operations.
Blank Slate builds the cognitive layer for organizations where mistakes are unacceptable. They apply modern brain science and adaptive AI to strengthen human performance at scale, reducing operational risk in the most demanding environments. Their platform is used by US Special Operations and Air Force F-16 and C-17 pilots, delivering measurable gains in accuracy, cognitive readiness, and real-world decision quality.
Cohere is the leading security-first enterprise AI company. We build cutting-edge foundation models and end-to-end AI products designed to solve real-world business problems. We partner closely with companies to deliver seamless integration, full customization, and easy-to-use solutions for their workforce and customers. Our all-in-one platform offers enterprises the highest levels of security, data privacy and optionality to deploy across all major cloud providers, private cloud environments, or on-premises.
DEFCON AI is an insights company delivering next-generation modeling, simulation, and analysis toolsets tailored for resilient optimization of complex systems. Leveraging their extensive expertise in artificial intelligence, mathematical optimization, data analytics, and world-class software engineering, their technology provides insights for better decisions in a complex and dynamically changing world. They empower clients to anticipate and mitigate potential impacts to network disruptions while aligning outcomes with operational goals.
Ethos Systems is the first Human Readiness Platform that combines learning, performance, and outcomes in one unified platform. The platform delivers modernized training, real-time readiness dashboards, and AI-driven personalization - all built for enterprise-scale deployment across both commercial and classified networks. Ethos serves over 150 enterprise customers across the U.S. military, life sciences, manufacturing, supply chain, and professional sports industries.
Jericho Security is a leading provider of AI-powered cybersecurity defensive solutions, specializing in spearphishing simulations and training against advanced social engineering threats, such as conversational phishing and deepfake attacks. Using agentic AI, Jericho provides realistic simulations across email, voice, and SMS that keep pace with real-world threats and that empowers teams to protect themselves.
Pryzm is the AI operating system for federal capture and acquisition. Built by alumni of Palantir and Lockheed Martin and designed for both commercial and federal users, Pryzm is trusted across the national security ecosystem to unify market intelligence, relationship insights, and real-time program awareness into a single, actionable view. The company is committed to ensuring the United States and its allies can rapidly field technology to the missions that matter most.
Research Innovations Inc. (RII) supports critical defense, intelligence, and cyber missions. RII's PRIISM Decision Advantage Platform is a Combined Joint All-Domain Command and Control (CJADC2) software product that provides mission-critical command, control, and decision support capabilities. PRIISM Joint Targeting Platform (JTP) rapidly accelerates the planning and dynamic execution of fires for both sovereign and coalition use cases. RII powers EW/SIGINT solutions with its Dragonfly platform, the first ever ruggedized, ultra-low SWaP, GPU-accelerated RF search and survey system for signal analysis and processing.
TrackVia is a leading low-code workflow platform that empowers organizations to rapidly configure, customize, and deploy highly configurable and customizable field service and operations solutions without the need for complex coding or extensive IT support. TrackVia helps organizations streamline processes, gain real-time reporting visibility, and improve operational efficiency.
About Second Front Systems
Second Front Systems (2F) is a public-benefit software company powering software for the free world. We eliminate the friction that slows innovation, enabling faster, more secure development and deployment of software across government and regulated networks. Built by national security veterans and backed by top-tier venture capital, our platform is trusted by the world's leading organizations to cut deployment timelines from years to weeks. We move fast, solve hard problems, and deliver trusted capabilities where they're needed most. Our work strengthens global security and gives the United States and its allies a lasting competitive advantage. Learn more at secondfront.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251203423146/en/
Contacts
press@secondfront.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom